Tobacco Documents Online

[Transmits Membership Contribution Check]

13 Mar 1989 1 p

Author: Frustace, H.
Recipient: Storr, H.G.

Information Required for Drawing and Mailing of Grant Checks [Amount of Payment for First Through Second Half Was $53,000]

Jul 1992 1 p

Author: CTR; Ruffen, W.
Recipient: Hansen, U.M.

Structural Proteins of Human Respiratory Coronavirus Oc43

1986 1 p

Author: Virus Research; Elsevier Science Publishers; Brian, D.A.; Hogue, B.G.

Effects of Sendai Virus and Vaccine on Short-Term Toxicological and Immunological Markers in Strain a/J Mice [Assesses Effects of Sendai Virus and Vaccine on Short-Term Markers in Mice]

17 Jun 1981 1 p

Author: Avery, M.D.; Collins, M.J.; Dansie, D.R.; Hall, W.C.; Henry, C.J.; Kouri, R.E.; Lubet, R.A.; Mckinney, C.; Putman, D.

Grant Application No. 2118 the Effect of Smoking on Eiconsanoid Metabolism in Normal and the Preeclamptic Pregnancies [Recommended Approval Without High Priority]

24 Mar 1987 3 pp

Author: Pierce
Recipient: Jarabak, J.

Permeability of Isolated Rat Lungs Perfused With Purine and Xanthine Oxidase Under Constant Perfusing Pressure Physiology of Oxygen Radicals American Physiological Society

1986 6 pp

Author: Demling, R.H.; Fox, R.B.; Merrigan, M.J.; Parad, R.B.

[Request by Burstein D That Upsent Balance From Third Year of Grant Be Extended Until June 30, 1993]

30 Dec 1992 1 p

Author: Burstein, D.
Recipient: Mcallister, H.C.

The Effect of Histamine and Cyclic Adenosine Monophosphate on Myosin Light Chain Phosphorylation in Human Umbilical Vein Endothelial Cells Volume 92

Sep 1993 10 pp

Author: Moy, A.B.; Moy, A.B.; Scott, B.D.; Scott, B.D.; Shasby, D.M.; Shasby, D.M.; Shasby, S.S.; Shasby, S.S.; J Clin Invest; Amer Society Clinical Investigation

Grant Application No. 1010 Carl G. Becker M.D., Cornell University [Discusses Merits and Concerns of Approving Becker Application]

No date 1 p

Author: Bing, R.J.

[No title]

02 Jun 1982 1 p

Author: Sommers, S.C.
Recipient: Lynch, H.

[Dup 300410920 -0920]

26 Mar 1963 1 p

Application Record (for 9xxa Series). Also for Listing Ratings by Area [Gives Procedure for Application Record]

Apr 1994 1 p

Processing New Incoming Applications [First Year Request 95,360 Second Year 97,903 Third Year 100,052]

Sep 1997 1 p

Author: MLA
Recipient: Jaynes, J.; Joklik; Vogt

5a 51-381

1950 2 pp

[Analytical Alternatives to Radioimmunoassay: a Review]

No date 28 pp

Author: Castro, A.; Malkus, H.; Monji, N.; Voigt, W.

Grant Number: 4191R2 [Supplemental Payment in Full and Second Half Payment to Grantee Berg KB]

11 Feb 1998 2 pp

Author: CTR
Recipient: Berg, D.K.; Larson, D.A.

Discussion We Have Good Reason to Promote General Risk Factor Reductions in Whole Populations World Health Forum Vol.5 [ST Defends Promotion of Large Scale Risk Factor Reduction]

1983 2 pp

Author: Finland Natl Public Health Inst; Univ Kuopio Research Inst of Public Health; BMJ; Koskela, K.; Nissinen, A.; Puska, P.; Salonen, J.T.; Tuomilehto, J.

#2880ar1 Krisans, Skaidrite

No date 1 p

Mutagenic Analysis of the V-CRK Oncogene: Requirement for SH2 and SH3 Domains and Correlation Between Increased Cellular Phosphotyrosine and Transformation Journal of Virology Vol. 64. No. 8

Aug 1990 9 pp

Author: Hanafusa, H.; Mayer, B.J.

[Transmits Letter]

10 Aug 1962 1 p

Author: Hanmer, H.R.
Recipient: Hoyt, W.T.

#1307B Springer, Timothy

1900 1 p

[Duplicate of 11303516]

16 Oct 1991 1 p

1913R1 Maccioni, Ricardo Prog. RPT. 1

1900 1 p

Progress Report Fellowship From the Tobacco Industry Research Committee for Studying the Culture of Human Lung Tissue and the Effects of Known and Possible Carcinogenic Agents Upon Such Tissue

31 Aug 1957 1 p

Author: Nakanishi, Y.H.

Oncogenes in Chemical Carcinogenesis.

14 Jan 1983 1 p

Author: Buchhagen, D.; Kauffman, S.L.